The role of ubiquitin-specific peptidases in cancer progression
2019 · Journal of Biomedical Science · 166 citations
https://doi.org/10.1186/s12929-019-0522-0
K
Kai‐Cheng Hsu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
208
Papers
4.0K
Citations
32
h-index
100
i10-index
Kai‐Cheng Hsu is an academic researcher from Taipei Medical University Hospital. The author has contributed to research in topics: Computational Drug Discovery Methods & Histone Deacetylase Inhibitors Research & Peptidase Inhibition and Analysis. The author has an h-index of 32, co-authored 177 publications.
ORCID: 0000-0002-9022-6673Papers by this author
worksDual Inhibition of PIK3C3 and FGFR as a New Therapeutic Approach to Treat Bladder Cancer
2017 · Clinical Cancer Research · 57 citations
https://doi.org/10.1158/1078-0432.ccr-17-2066
Applying density-based outlier identifications using multiple datasets for validation of stroke clinical outcomes
2019 · International Journal of Medical Informatics · 33 citations
https://doi.org/10.1016/j.ijmedinf.2019.103988
Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities
2013 · Organic & Biomolecular Chemistry · 32 citations
https://doi.org/10.1039/c3ob40624e
An ATP-sensitive phosphoketolase regulates carbon fixation in cyanobacteria
2023 · Nature Metabolism · 32 citations
https://doi.org/10.1038/s42255-023-00831-w
Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment
2021 · Biomedicine & Pharmacotherapy · 22 citations
https://doi.org/10.1016/j.biopha.2021.112459
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat